Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
Hospices Civils de Lyon, Hopital Louis Pradel, Department of Anesthesiology, Bron, France
Anesthesiology Service of Univeritary Hospital of Bellvitge, Hospitalet . Barcelona, Barcelona, Spain
Piracicaba Dental School, Piracicaba, Sao Paulo, Brazil
UHAngers, Angers, France
Hvidovre University Hospital, Copenhagen, Hvidover, Denmark
Hørsholm Hospital, Hørsholm, Denmark
Departement of childrens orthopaedics, Aarhus University Hospital, Aarhus, Denmark
CHA-Pavillon Enfant-Jésus, Québec, Quebec, Canada
Joint Reconstruction Center, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Hvidovre University Hospital, Copenhagen, Hvidovre, Denmark
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.